Praxis Precision Medicines, Inc. (PRAX)
356.88
+6.28
(+1.79%)
USD |
NASDAQ |
May 27, 16:00
356.88
0.00 (0.00%)
After-Hours: 16:39
Praxis Precision Medicines Cash from Investing (Quarterly) : -344.28M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -36.46M |
| Bridgebio Oncology Therapeutics, Inc. | -285.41M |
| Spyre Therapeutics, Inc. | 56.58M |
| Erasca, Inc. | -243.83M |
| ADMA Biologics, Inc. | 2.404M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -86.05M |
| Cash from Financing (Quarterly) | 609.33M |
| Free Cash Flow | -282.53M |
| Free Cash Flow Per Share (Quarterly) | -2.981 |
| Free Cash Flow to Equity (Quarterly) | -87.44M |
| Free Cash Flow to Firm (Quarterly) | -86.11M |
| Free Cash Flow Yield | -3.24% |